Response to letter regarding article, “High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy.”

Схожие документы

• HDL cholesterol, size, particle number, and residual vascular risk after potent statin therapy
  по: Mora, Samia, et al.
  Опубликовано: (2013)
• On-Treatment Non-HDL Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk after Treatment with Potent Statin Therapy: The JUPITER Trial
  по: Mora, Samia, et al.
  Опубликовано: (2012)
• Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
  по: Lawler, Patrick R., et al.
  Опубликовано: (2017)
• Association of Air Pollution Exposures with High Density Lipoprotein Cholesterol and Particle Number: The Multi-Ethnic Study of Atherosclerosis
  по: Bell, Griffith, et al.
  Опубликовано: (2017)
• Cholesterol Efflux Capacity, HDL Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
  по: Khera, Amit V., et al.
  Опубликовано: (2017)